AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-118769560/merck-submits-arthritis-drug.html" title="Facts and information about Merck Submits Arthritis Drug to FDA for Approval.">Merck Submits Arthritis Drug to FDA for Approval.</a>

Close Set up an RSS feed that alerts you when new articles from The Record (Hackensack, NJ) are available.

Frequently asked questions about RSS feeds

Merck Submits Arthritis Drug to FDA for Approval.

The Record (Hackensack, NJ)

| January 08, 2004 | COPYRIGHT 2007 The Record. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Lewis Krauskopf

Jan. 8--Merck & Co. met its self-imposed deadline to Wall Street by a whisker last week when it submitted its new arthritis drug for approval before the calendar turned to 2004.

But the drug, Arcoxia, is still overdue.

Merck took the unusual step in 2002 of withdrawing its first Arcoxia application. The drug maker said it wanted to expand the potential uses for the drug and to add data.

Now, as Merck files the drug again with the Food and Drug Administration, Arcoxia is as important as ever to the Whitehouse Station-based drug maker, which was plagued by failures in its experimental drug pipeline in 2003.

Some analysts forecast the pill as one of the company's next…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


New drug for arthritis?: Merck seeking FDA approval for Arcoxia, a chemical...: Newspaper article from: Newsday (Melville, NY) March 21, 2007 700+ words
...Drug Administration approves Arcoxia, Merck could recoup some of those sales...brands Cataflam and Voltaren. Merck says Arcoxia users had somewhat fewer heart...Plainview Hospital, also tested Arcoxia for Merck and said most of his patients...


Merck submits new data for Arcoxia.: News wire article from: Europe Intelligence Wire November 10, 2006 700+ words
...stroke. In August, Merck said a preliminary analysis showed Arcoxia didn't raise those...could allow U.S. Arcoxia sales. Merck currently is seeking...nine months of 2006. Merck began developing Arcoxia in 1999, the year Vioxx...


FDA rejects Merck's Arcoxia: It was a successor to Vioxx, which the firm had...: Newspaper article from: Philadelphia Inquirer (Philadelphia, PA) April 28, 2007 700+ words
...nonapprovable" letter for Arcoxia stating that "Merck would need to provide...ibuprofen and naproxen. Merck had been awaiting approval of Arcoxia since December 2003...milligram doses. But Arcoxia came under increased scrutiny after Merck withdrew Vioxx in...


Large outcomes study showed Merck's Arcoxia (etoricoxib) had similar rates of...: News wire article from: Chemical Business Newsbase November 13, 2006 700+ words
...NewsBase - Press Release) Merck & Co Inc announced...selective COX-2 inhibitor Arcoxia (etoricoxib) demonstrated...following daily treatment of Arcoxia (60 mg or 90 mg daily...Foundation of Madison, WI. Arcoxia is Merck & Co Inc's investigational...


MSD launches new formulation of Arcoxia.(Merck Sharpe and Dohm product...: Newspaper article from: Pharma Marketletter May 15, 2006 700+ words
Merck Sharpe and Dohm, the UK subsidiary of US drug major Merck & Co, has introduced novel...steroidal anti-inflammatory drug Arcoxia (etoricoxib), providing a...recent European Union guidance. Arcoxia is indicated for the symptomatic...


Merck gives FDA Arcoxia MEDAL.(Noted): Magazine article from: Pharmaceutical Processing December 1, 2006 700+ words
Merck gives FDA Arcoxia MEDAL: Merck has submitted a response to FDA's "approvable" letter for Vioxx follow-on Arcoxia (etoricoxib), setting an April 2007 user fee action date, the...


Arcoxia refused approval.(Merck & Company Inc.)(Brief article): Magazine article from: Chemistry and Industry May 7, 2007 700+ words
...Administration (FDA) has refused to approve Merck's painkiller Arcoxia. The FDA told Merck that it would need to provide more evidence...committee, which concluded that the risks of Arcoxia outweigh its benefits (C&I 2007, 8...


Merck Pulls Request for FDA's Approval of Painkiller Arcoxia.: News wire article from: Record (Hackensack, NJ) March 16, 2002 700+ words
...digit earnings increase for 2003. Arcoxia is planned as Merck's second offering, after the pill...potential side effects was the reason Merck pulled the Arcoxia filing. Christine Fanelle, a Merck spokeswoman, said that the company...


Merck Provides Preliminary Analyses of the Completed MEDAL Program for...: Press release article from: Business Wire August 23, 2006 700+ words
...interval below 1.30. About ARCOXIA ARCOXIA is Merck & Co., Inc.'s selective...for ARCOXIA in October 2004. ARCOXIA is currently available in 62 countries...East/Northern Africa. About Merck Merck & Co., Inc. is...


Merck to Refile Arcoxia NDA.(Brief Article): Newspaper article from: Drug Discovery & Technology News June 1, 2002 700+ words
...Investors were expecting Merck to refile the Arcoxia application much...safety data (on Arcoxia). It calls into question Merck's Cox-2 franchise...forward.'' Without Arcoxia, says Greene, investors don't believe Merck's earning forecast...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: